These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29933028)

  • 1. Drawing a link between the thromboxane A
    Serhan K; Gartung A; Panigrahy D
    Prostaglandins Other Lipid Mediat; 2018 Jul; 137():40-45. PubMed ID: 29933028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism.
    Yuan L; Liu X
    Mol Med Rep; 2015 Apr; 11(4):2449-58. PubMed ID: 25502723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sushi Domain Containing 2 (SUSD2) inhibits platelet activation and binding to high-grade serous ovarian carcinoma cells.
    Lager TW; Roetman JJ; Kunkel J; Thacker M; Sheets JN; Egland KA; Miles CM; Larson MK; Gubbels JAA
    Platelets; 2018 Dec; 29(8):834-837. PubMed ID: 30335544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.
    Orellana R; Kato S; Erices R; Bravo ML; Gonzalez P; Oliva B; Cubillos S; Valdivia A; Ibañez C; Brañes J; Barriga MI; Bravo E; Alonso C; Bustamente E; Castellon E; Hidalgo P; Trigo C; Panes O; Pereira J; Mezzano D; Cuello MA; Owen GI
    BMC Cancer; 2015 Apr; 15():290. PubMed ID: 25886038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
    Valeri CR; Macgregor H; Ragno G
    Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.
    Cooke NM; Spillane CD; Sheils O; O'Leary J; Kenny D
    BMC Cancer; 2015 Sep; 15():627. PubMed ID: 26353776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thromboxane A2 inhibition on osteogenic sarcoma cell-induced platelet aggregation.
    Mehta P; Lawson D; Ward MB; Lee-Ambrose L; Kimura A
    Cancer Res; 1986 Oct; 46(10):5061-3. PubMed ID: 3463411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.
    Hu Q; Hisamatsu T; Haemmerle M; Cho MS; Pradeep S; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Wong STC; Sood AK; Afshar-Kharghan V
    Clin Cancer Res; 2017 Sep; 23(18):5611-5621. PubMed ID: 28611202
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion.
    Polat M; Senol T; Ozkaya E; Ogurlu Pakay G; Cikman MS; Konukcu B; Ozten MA; Karateke A
    Clin Transl Oncol; 2016 May; 18(5):457-63. PubMed ID: 26289552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometriosis-Derived Stromal Cells Secrete Thrombin and Thromboxane A2, Inducing Platelet Activation.
    Guo SW; Du Y; Liu X
    Reprod Sci; 2016 Aug; 23(8):1044-52. PubMed ID: 26902428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamics of morphological structures of platelets in patients with ischemic heart disease in dependence on blood levels of fatty acids].
    Sokolov EI; Buriachkovskaia LI; Zykova AA; Goloborodova IV
    Kardiologiia; 2011; 51(1):29-33. PubMed ID: 21626799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
    Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
    Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
    Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
    Swier N; Versteeg HH
    Thromb Res; 2017 Feb; 150():8-18. PubMed ID: 27988375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and metastasis revisited: a novel fatty link.
    Gupta GP; Massagué J
    J Clin Invest; 2004 Dec; 114(12):1691-3. PubMed ID: 15599391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets.
    Li S; Li X; Li J; Deng X; Li Y
    Steroids; 2007 Nov; 72(13):875-80. PubMed ID: 17825336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors.
    Brantl SA; Khandoga AL; Siess W
    Platelets; 2014; 25(6):465-6. PubMed ID: 24102401
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.